FALLS CHURCH, Va., Oct. 4, 2018 /PRNewswire-PRWeb/ -- 13th Annual FDA Inspections Summit: **Presented by FDAnews**
David Glasgow, Deputy Director, Office of Bioresearch Monitoring Operations, OMPTO, ORA, FDA has been confirmed as a speaker at the13th Annual FDAnews Inspections Summit.
So much has changed since last year's Inspections Summit that it sometimes feels difficult to keep up. The FDA is focused on any number of new topics: more generics, lower prices, opioids, internal restructuring, and much more. But one thing that hasn't changed is that they are still doing inspections and the regulated community is still making mistakes.
The FDA will always do inspections, and Commissioner Scott Gottlieb and the FDA have certainly not provided any hint that they are going to stop doing them any time soon.
Manufacturers can't afford to be caught off guard. Warning letters and 483 citations can cost manufacturers time, energy and money.
Come to Washington, DC, Oct. 23-25, for the 13th Annual FDA Inspections Summit, the must-attend conference of the regulatory year from FDAnews.
Attend in person or live-stream the summit. The entire conference, including standout pre-conference workshops, is available in real time via livestreaming.
Who Will Benefit:
Conference Details 13th Annual FDA Inspections Summit: **Presented by FDAnews** Oct. 23-25, 2018 – Bethesda, MD http://www.fdanews.com/fdainspectionssummit
Tuition: In-Person Complete Summit: $1,997 Livestream Complete Summit: $1,497 Additional pricing options are available online.
Easy Ways to Register: Online: http://www.fdanews.com/fdainspectionssummit By phone: 888-838-5578 or 703-538-7600
About FDAnews: FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.
Subscribe to our Free Newsletters!